A
Anushka Patel
Researcher at The George Institute for Global Health
Publications - 337
Citations - 29250
Anushka Patel is an academic researcher from The George Institute for Global Health. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 69, co-authored 315 publications receiving 25272 citations. Previous affiliations of Anushka Patel include Northwestern University & Ministry of Health (New South Wales).
Papers
More filters
Journal ArticleDOI
INterpreting the Processes of the UMPIRE Trial (INPUT): protocol for a qualitative process evaluation study of a fixed-dose combination (FDC) strategy to improve adherence to cardiovascular medications.
Abdul Salam,Frances Stewart,Kavita Singh,Simon Thom,Hilarie Williams,Anushka Patel,Stephen Jan,Tracey Laba,Dorairaj Prabhakaran,Pallab K. Maulik,Sophie E. Day,Helen Ward +11 more
TL;DR: The process evaluation will help inform and enhance the understanding of the UMPIRE trial results and its applicability to clinical practice as well as shaping policy regarding strategies for improving cardiovascular medication adherence.
Journal ArticleDOI
An integrated general practice and pharmacy-based intervention to promote the use of appropriate preventive medications among individuals at high cardiovascular disease risk: protocol for a cluster randomized controlled trial.
Adina Hayek,Adina Hayek,Rohina Joshi,Rohina Joshi,Tim Usherwood,Tim Usherwood,Ruth Webster,Ruth Webster,Baldeep Kaur,Baldeep Kaur,Bandana Saini,Bandana Saini,Carol L. Armour,Carol L. Armour,Ines Krass,Tracey-Lea Laba,Tracey-Lea Laba,Christopher M. Reid,Christopher M. Reid,Louise Shiel,Charlotte Hespe,Fred Hersch,Stephen Jan,Stephen Jan,Serigne Lo,Serigne Lo,David Peiris,David Peiris,Anthony Rodgers,Anthony Rodgers,Anushka Patel,Anushka Patel +31 more
TL;DR: The primary outcome is the proportion of patients at high CVD risk who were inadequately treated at baseline who achieve target blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C) levels at the study end.
Journal ArticleDOI
Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease
Duncan J. Campbell,Duncan J. Campbell,Bruce Neal,John Chalmers,Samuel A. Colman,Alicia J. Jenkins,Bruce E. Kemp,Bruce E. Kemp,Bruce E. Kemp,Anushka Patel,Stephen MacMahon,Mark Woodward +11 more
TL;DR: SBP predicted ICHrisk in subjects with cerebrovascular disease, whereas CRP, sVCAM-1, homocysteine, NT-proBNP, and renin did not predict ICH risk, and trends for prediction of ICH Risk by mean LDL particle diameter and large LDL particle concentration are hypothesis generating and require confirmation in larger studies.
Journal ArticleDOI
Ultra-low-dose quadruple combination blood pressure-lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol
Clara K Chow,Clara K Chow,Emily Atkins,Laurent Billot,John Chalmers,Graham S. Hillis,Peter Hay,Bruce Neal,Mark Nelson,Anushka Patel,Christopher M. Reid,Markus P. Schlaich,Tim Usherwood,Ruth Webster,Anthony Rodgers +14 more
TL;DR: The hypothesis is that a single-pill combination of four blood pressure- lowering agents each at a quarter dose may provide a simple, safe and effective blood pressure lowering solution which may also improve long term-adherence.